FOR IMMEDIATE RELEASE
SYNDEO Medical, a global leader in the design and development of fully integrated custom procedural solution products, is pleased to introduce Chlorhexidine (CHG) Patient Preoperative Skin Preparation, now available in SYNDEOPack™ interventional procedure packs.
Recognizing the need for a more accessible and efficient solution, SYNDEO Medical has expanded its SYNDEOPack™ line to include CHG Patient Preoperative Skin Preparation. This cost-effective and convenient addition offers healthcare providers a valuable method of procuring Chlorhexidine (CHG) for their interventional procedures, providing convenience and value.
The CHG Patient Preoperative Skin Preparation is available in a variety of sizes, including 3mL, 5mL, 10.5mL, and 26mL, catering to different procedural requirements. Additionally, healthcare providers have the option to choose between tinted and non-tinted configurations, providing flexibility based on individual preferences and procedural needs.
"Introducing the CHG Patient Preoperative Skin Preparation in SYNDEOPack™ marks another significant step in our commitment to delivering innovative solutions that enhance patient outcomes," said Justin J. Lampropoulos, CEO of SYNDEO Medical. "Chlorhexidine, known as CHG, has long been recognized as a gold standard in skin preparation, playing a vital role in the prevention of surgical site infections (SSIs) during interventional procedures. With its availability in a range of sizes and the option for tinted and non-tinted configurations, healthcare providers can effectively apply CHG with convenience and precision, ensuring optimal patient safety."
This CE marked solution is available in relevant jurisdictions, subject to local regulatory approvals where applicable.
For more information on incorporating the CHG Patient Preoperative Skin Preparation into your interventional procedure pack, please contact SYNDEO Medical or visit syndeomedical.com.
SYNDEO Medical is engaged in the design and development of fully integrated custom procedural solution products. Founded in 2022 by Justin Lampropoulos and headquartered in Belgium, SYNDEO Medical is dedicated to pushing the boundaries of healthcare innovation. Specializing in minimally invasive interventional and surgical products, SYNDEO Medical serves healthcare providers worldwide through a network of distribution partners and sales representatives. The company is committed to positively impacting lives through elevating patient experience, delivering meaningful value, and empowering outcomes.
Disclaimer: All trademarks and registered trademarks mentioned in this press release are the property of their respective owners. The availability of products may vary in different jurisdictions. Availability is subject to compliance with local regulatory requirements.